Cilazapril Monohydrate
Grundinformationen
- CAS
92077-78-6- Standard-SMILES
CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCCN2CCC[C@@H](C(=O)O)N2C1=O.O- InChIKey
JQRZBPFGBRIWSN-YOTVLOEGSA-N- Summenformel
- C22H33N3O6
- Durchschnittliche Molmasse
- 435,5 g/mol
- Monoisotopische Masse
- 435,23693578
Überblick
Cilazapril monohydrate is a hydrate that is the monohydrate of cilazapril. It is used for the treatment of hypertension and heart failure. It has a role as an EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor, an antihypertensive agent and a prodrug. It contains a cilazapril.
Namen und Bezeichner
- Bevorzugter Name
- Cilazapril Monohydrate
- IUPAC
- (4S,7S)-7-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-6-oxo-1,2,3,4,7,8,9,10-octahydropyridazino[1,2-a]diazepine-4-carboxylic acid;hydrate
- Englischer Name
- Cilazapril Monohydrate
- Summenformel
- C22H31N3O5.H2O
- Molmasse
- 435.51
Namen und Synonyme
Weitere Namen anzeigen
Datenbank-Bezeichner
- CAS
92077-78-6- PubChem CID
- 56329
- DTXSID
DTXSID00238846- ChEBI
CHEBI:145568- UNII
- 19KW7PI29F
- EC Number
- 620-542-7
Eigenschaften
Berechnete Struktureigenschaften
- Polarare Oberfläche (TPSA)
- 100 Ų
- H-Brücken-Donoren
- 3
- H-Brücken-Akzeptoren
- 8
- Frei drehbare Bindungen
- 9
- Schwere Atome
- 31
- Formalladung
- 0
- Komplexität
- 608
Physikochemische Eigenschaften
- Schmelzpunkt
- 98 ° · 98° (dec)
- storage temp.
- -20 °C · Store at -20°C
- Löslichkeit
- Slightly soluble in water, freely soluble in methanol and in methylene chloride.
- Aggregatzustand
- Solid
- pka
- 1 · pKa1 3.3; pKa2 6.4(at 25℃)
- Farbe
- White to off-white
- Major Application
- pharmaceutical (small molecule)
- InChIKey
- JQRZBPFGBRIWSN-YOTVLOEGSA-N
- SMILES
- N21N(CCC[C@H]2C(=O)O)CCC[C@@H](C1=O)N[C@@H](CCc3ccccc3)C(=O)OCC.O
Sicherheit und Regulatorisches
GHS-Klassifizierung
GHS Classification
Warning
H361 (100%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]
P203, P280, P318, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 3 reports by companies from 2 notifications to the ECHA C&L Inventory.
Gefahrenhinweise
Sicherheitsdaten
- Alarmwort
- Warnung
- Gefahrenhinweise
- Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code H361
Chemie und Industrie
Pharmakologische Informationen
MeSH Pharmacological Classification
A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility.
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.
Anwendungen
BeschreibungCilazapril is a new ACE inhibitor useful in the management of mild to moderate hypertension. Orally administered cilazapril is a prodrug which is de-esterified to its active diacid metabolite cilazprilat. Compared with enalapril and captopril, cilazapril is more potent and longer lasting.
VerwendenAntihypertensive.
Vor- und nachgelagerte Produkte
Vorgelagerte Rohstoffe
Anbieter45 Anbieter
Zugehörige Reaktionen
Notizen zur Verbindung
Wird geladen…